Kawasumi Laboratories financials at a glance
| Year | Year | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
28.61B | 28.66B | 30.80B | 31.45B | 30.37B | 30.98B | 32.11B | 30.35B | 27.83B | 27.63B | 28.41B | 28.14B | 24.73B | 25.44B | 24.10B | 22.32B | 0.00M | 0.00M |
| GM % | Gross Margin % |
|
25.75% | 25.58% | 25.00% | 27.49% | 32.48% | 35.09% | 33.24% | 30.91% | 30.69% | 32.61% | 33.55% | 36.00% | 35.84% | 34.14% | 34.05% | 33.83% | 0.00% | 0.00% |
| OM | Operating Margin |
|
2.23% | 1.45% | 2.04% | 4.16% | 7.33% | 9.12% | 7.37% | 4.82% | 1.42% | 0.90% | 4.95% | 7.57% | 3.74% | 2.70% | 2.40% | 2.81% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
0.00 | 0.00 | ||||||||||||||||
| Div. | Dividends |
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
19.42m | 19.41m | 19.4m | 22.89m | 22.89m | 22.88m | 22.87m | 22.87m | 22.87m | 22.87m | 22.87m | 22.87m | 21.82m | 21.82m | 20.62m | 20.67m | 0m | 0m |
| OCF | Operating Cash Flow |
|
1.99B | 2.50B | 2.64B | 4.31B | 3.81B | 3.43B | 3.60B | 5.39B | 3.31B | 4.57B | 5.06B | 3.23B | 2.95B | 2.76B | 1.39B | 2.34B | 0.00M | 0.00M |
| FCF | Free Cash Flow |
|
485.00M | -921.00M | 494.00M | 3.19B | 2.03B | 30.00M | 511.00M | 4.11B | 656.00M | 188.00M | 4.20B | 2.47B | 2.26B | 1.97B | 581.00M | 1.50B | 0.00M | 0.00M |
| FCFS | Free Cash Flow Per Share |
|
24.98 | -47.46 | 25.00 | 137.69 | 67.98 | 1.31 | 36.25 | 99.31 | -42.81 | 49.76 | 189.53 | 127.54 | 22.64 | 93.65 | 31.95 | 32.88 | 0.00 | 0.00 |